Search research articles
Contact Us
Filters
Showing results (71-80 of 195) with videos related to
Page
of 20
Sort By:
The Journal of Pharmacy and Pharmacology
|
March 1, 1997
Optimization of the chiral inversion of 2-phenylpropionic acid by Verticillium lecanii
M J Thomason, W Rhys-Williams, A W Lloyd, et al.
BMJ Open Quality
|
July 29, 2020
Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital
Melanie Nana, Cherry Shute, Rhys Williams, et al.
Journal of Medical Economics
|
December 16, 2021
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population
Aditi Kadakia, Brenna L Brady, Carole Dembek, et al.
The Journal of Antimicrobial Chemotherapy
|
August 20, 2009
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
Nicola Ooi, Keith Miller, Joanne Hobbs, et al.
Clinical Therapeutics
|
May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy
Ariel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 29, 2002
Is sepsis accurately coded on hospital bills?
Daniel A Ollendorf, A Mark Fendrick, Karen Massey, et al.
Patient Education and Counseling
|
July 25, 2006
Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial
Adrian Edwards, Richard Thomas, Rhys Williams, et al.
The American Journal of Managed Care
|
September 19, 2022
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics
Aditi Kadakia, Brenna L Brady, Carole Dembek, et al.
The Journal of Antimicrobial Chemotherapy
|
November 6, 2009
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
Nicola Ooi, Keith Miller, Christopher Randall, et al.
Journal of Comparative Effectiveness Research
|
November 4, 2022
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA
Darshan Mehta, Inyoung Lee, Hangcheng Liu, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 195) with videos related to
Sort By:
Page
of 20
The Journal of Pharmacy and Pharmacology
|
March 1, 1997
Optimization of the chiral inversion of 2-phenylpropionic acid by Verticillium lecanii
M J Thomason, W Rhys-Williams, A W Lloyd, et al.
BMJ Open Quality
|
July 29, 2020
Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital
Melanie Nana, Cherry Shute, Rhys Williams, et al.
Journal of Medical Economics
|
December 16, 2021
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population
Aditi Kadakia, Brenna L Brady, Carole Dembek, et al.
The Journal of Antimicrobial Chemotherapy
|
August 20, 2009
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
Nicola Ooi, Keith Miller, Joanne Hobbs, et al.
Clinical Therapeutics
|
May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy
Ariel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 29, 2002
Is sepsis accurately coded on hospital bills?
Daniel A Ollendorf, A Mark Fendrick, Karen Massey, et al.
Patient Education and Counseling
|
July 25, 2006
Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial
Adrian Edwards, Richard Thomas, Rhys Williams, et al.
The American Journal of Managed Care
|
September 19, 2022
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics
Aditi Kadakia, Brenna L Brady, Carole Dembek, et al.
The Journal of Antimicrobial Chemotherapy
|
November 6, 2009
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
Nicola Ooi, Keith Miller, Christopher Randall, et al.
Journal of Comparative Effectiveness Research
|
November 4, 2022
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA
Darshan Mehta, Inyoung Lee, Hangcheng Liu, et al.
Page
of 20